LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL
Lipids in Health and Disease · 2024
DOI: 10.1186/s12944-024-02068-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lipids in Health and Disease, 2024. Verfasst von Kaihan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type II. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key Technology R&D Program of Ningbo, the Key Laboratory of Precision Medicine for Atherosclerotic Disease of Zhejiang Province.
Abstract (Originalsprache)
Background
Familial hypercholesterolemia (FH) is a prevalent hereditary disease that can cause aberrant cholesterol metabolism. In this study, we confirmed that c.415G > A in low-density lipoprotein receptor ( LDLR ), an FH-related gene, is a pathogenic variant in FH by in silico analysis and functional experiments.
Methods
The proband and his family were evaluated using the diagnostic criteria of the Dutch Lipid Clinic Network. Whole-exome and Sanger sequencing were used to explore and validate FH-related variants. In silico analyses were used to evaluate the pathogenicity of the candidate variant and its impact on protein stability. Molecular and biochemical methods were performed to examine the effects of the LDLR c.415G > A variant in vitro.
Results
Four of six participants had a diagnosis of FH. It was estimated that the LDLR c.415G > A variant in this family was likely pathogenic. Western blotting and qPCR suggested that LDLR c.415G > A does not affect protein expression. Functional studies showed that this variant may lead to dyslipidemia by impairing the binding and absorption of LDLR to low-density lipoprotein ( LDL).
Conclusion
LDLR c.415G > A is a pathogenic variant in FH; it causes a significant reduction in LDLR’s capacity to bind LDL, resulting in impaired LDL uptake. These findings expand the spectrum of variants associated with FH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
- Department of Cardiology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, Zhejiang, China.
- Department of Gastroenterology, Ningbo Ninth Hospital, Ningbo, Zhejiang, China.
- Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China. shaoyi_lin@hotmail.com.
- Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China. chxmin@hotmail.com.
Förderung
- the Key Technology R&D Program of Ningbo
- the Key Laboratory of Precision Medicine for Atherosclerotic Disease of Zhejiang Province
Zitieren
APA
Wang, K., Hu, T., Tai, M., Shen, Y., Chai, H., Lin, S., & Chen, X. (2024). LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL. Lipids in Health and Disease. https://doi.org/10.1186/s12944-024-02068-2
Vancouver
Wang K, Hu T, Tai M, Shen Y, Chai H, Lin S, et al. LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL. Lipids in Health and Disease. 2024. doi:10.1186/s12944-024-02068-2
BibTeX
@article{Wang2024,
author = {Wang, Kaihan and Hu, Tingting and Tai, Mengmeng and Shen, Yan and Chai, Haocheng and Lin, Shaoyi and Chen, Xiaomin},
title = {LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL},
journal = {Lipids in Health and Disease},
year = {2024},
doi = {10.1186/s12944-024-02068-2}
}
EUVIMED